News

Merkel Cell Carcinoma: Update and Review


 

Timothy S. Wang, MD, Patrick J. Byrne, MD, FACS, Lisa K. Jacobs, MD, and Janis M. Taube, MD

Merkel cell carcinoma (MCC) is a rare, aggressive, and often fatal cutaneous malignancy that is not usually suspected at the time of biopsy. Because of its increasing incidence and the discovery of a possible viral association, interest in MCC has escalated. Recent effort has broadened our breadth of knowledge regarding MCC and developed instruments to improve data collection and future study. This article provides an update on current thinking about the Merkel cell and MCC.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

AAD: Lasers for Pigmentary Disorders: Yes, No, and Maybe
MDedge Dermatology
Photodynamic Therapy Protocols Differ by Location
MDedge Dermatology
Cosmetic Industry Leading Nanotechnology Market
MDedge Dermatology
AAD: Cancer Patients With Skin Conditions Not Being Referred
MDedge Dermatology
New Options for Field Therapy: MAL-PDT Plus Red LED
MDedge Dermatology
Blog: Skin Cancer Screening RV Makes AAD Pit Stop
MDedge Dermatology
AAD: Melanoma Underreported to Cancer Registries
MDedge Dermatology
Percutaneous Hepatic Perfusion Boosts Melanoma Response
MDedge Dermatology
AAD: Skin Cancer Incidence Continuing to Rise
MDedge Dermatology
The Role of Targeted Molecular Inhibitors in the Management of Advanced Nonmelanoma Skin Cancer
MDedge Dermatology